Palm and partially hydrogenated soybean oils adversely alter lipoprotein profiles compared with soybean and canola oils in moderately hyperlipidemic subjects

Am J Clin Nutr. 2006 Jul;84(1):54-62. doi: 10.1093/ajcn/84.1.54.

Abstract

Background: Partially hydrogenated fat has an unfavorable effect on cardiovascular disease risk. Palm oil is a potential substitute because of favorable physical characteristics.

Objective: We assessed the effect of palm oil on lipoprotein profiles compared with the effects of both partially hydrogenated fat and oils high in monounsaturated or polyunsaturated fatty acids.

Design: Fifteen volunteers aged > or =50 y with LDL cholesterol > or =130 mg/dL were provided with food for each of 4 diets (35 d/phase) varying in type of fat (partially hydrogenated soybean, soybean, palm, or canola; two-thirds fat, 20% of energy). Plasma fatty acid profiles, lipids, lipoproteins, apolipoprotein A-I, apolipoprotein B, lipoprotein(a), glucose, insulin, HDL subfractions, and indicators of lipoprotein metabolism (HDL-cholesterol fractional esterification rate, cholesteryl ester transfer protein, phospholipid transfer protein, and paraoxonase activities) were measured at the end of each phase.

Results: Plasma fatty acid profiles reflected the main source of dietary fat. Partially hydrogenated soybean and palm oils resulted in higher LDL-cholesterol concentrations than did soybean (12% and 14%, respectively; P < 0.05) and canola (16% and 18%; P < 0.05) oils. Apolipoprotein B (P < 0.05) and A-I (P < 0.05) concentrations mirrored the pattern of LDL- and HDL-cholesterol concentrations, respectively. No significant effect on the total-to-HDL cholesterol ratio was observed for palm oil compared with the other dietary fats. HDL3 cholesterol was higher after palm oil than after partially hydrogenated and soybean oils (P < 0.05). Differences in measures of glucose and HDL intravascular processing attributable to dietary fat were small.

Conclusion: Palm and partially hydrogenated soybean oils, compared with soybean and canola oils, adversely altered the lipoprotein profile in moderately hyperlipidemic subjects without significantly affecting HDL intravascular processing markers.

Publication types

  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Aged
  • Apolipoproteins / blood
  • Apolipoproteins / drug effects
  • Apolipoproteins B / blood
  • Apolipoproteins B / drug effects
  • Blood Glucose / drug effects
  • Blood Glucose / metabolism
  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / epidemiology
  • Cholesterol, HDL / blood*
  • Cholesterol, HDL / drug effects
  • Cholesterol, LDL / blood*
  • Cholesterol, LDL / drug effects
  • Cross-Over Studies
  • Fatty Acids / analysis
  • Fatty Acids / blood*
  • Fatty Acids / metabolism
  • Fatty Acids, Monounsaturated / administration & dosage
  • Fatty Acids, Monounsaturated / pharmacology
  • Female
  • Humans
  • Hydrogenation
  • Hyperlipidemias / blood*
  • Hyperlipidemias / complications
  • Hyperlipidemias / diet therapy
  • Lipoprotein(a) / blood
  • Lipoprotein(a) / drug effects
  • Male
  • Middle Aged
  • Palm Oil
  • Plant Oils / administration & dosage
  • Plant Oils / adverse effects*
  • Plant Oils / pharmacology
  • Rapeseed Oil
  • Risk Factors
  • Soybean Oil / administration & dosage
  • Soybean Oil / pharmacology
  • Triglycerides / blood

Substances

  • Apolipoproteins
  • Apolipoproteins B
  • Blood Glucose
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Fatty Acids
  • Fatty Acids, Monounsaturated
  • Lipoprotein(a)
  • Plant Oils
  • Rapeseed Oil
  • Triglycerides
  • Palm Oil
  • Soybean Oil